Literature DB >> 7520606

Pseudomonas cepacia in cystic fibrosis.

D E Stableforth, D L Smith.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7520606      PMCID： PMC475044          DOI： 10.1136/thx.49.7.629

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  20 in total

1.  Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.

Authors:  J J LiPuma; J E Mortensen; S E Dasen; T D Edlind; D V Schidlow; J L Burns; T L Stull
Journal:  J Pediatr       Date:  1988-11       Impact factor: 4.406

2.  Pseudomonas cepacia--fatal pulmonary infection in a patient with cystic fibrosis.

Authors:  S Glass; J R Govan
Journal:  J Infect       Date:  1986-09       Impact factor: 6.072

3.  Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis.

Authors:  M J Thomassen; C A Demko; C F Doershuk; R C Stern; J D Klinger
Journal:  Am Rev Respir Dis       Date:  1986-10

4.  Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.

Authors:  D L Smith; L B Gumery; E G Smith; D E Stableforth; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

5.  Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin.

Authors:  G Nolan; P Moivor; H Levison; P C Fleming; M Corey; R Gold
Journal:  J Pediatr       Date:  1982-10       Impact factor: 4.406

Review 6.  Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology.

Authors:  D A Goldmann; J D Klinger
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406

7.  Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.

Authors:  M J Thomassen; C A Demko; J D Klinger; R C Stern
Journal:  Am Rev Respir Dis       Date:  1985-05

8.  Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

Authors:  O C Tablan; T L Chorba; D V Schidlow; J W White; K A Hardy; P H Gilligan; W M Morgan; L A Carson; W J Martone; J M Jason
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

9.  Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients.

Authors:  K A Hardy; K L McGowan; M C Fisher; D V Schidlow
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406

10.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948
View more
  9 in total

Review 1.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

2.  Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis.

Authors:  S K Fung; H Dick; H Devlin; E Tullis
Journal:  Can J Infect Dis       Date:  1998-05

Review 3.  The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?

Authors:  D Banerjee; D Stableforth
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

4.  Subdural empyema due to Burkholderia cepacia: an unusual complication after lung transplantation for cystic fibrosis.

Authors:  I M Balfour-Lynn; H C Ryley; B F Whitehead
Journal:  J R Soc Med       Date:  1997       Impact factor: 18.000

5.  Prevention of cross infection during outpatient spirometry.

Authors:  J Marchant; A Bush
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

Review 6.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 7.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

8.  Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.

Authors:  K Muhdi; F P Edenborough; L Gumery; S O'Hickey; E G Smith; D L Smith; D E Stableforth
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

9.  Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.

Authors:  M McCloskey; J McCaughan; A O Redmond; J S Elborn
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.